Skip to main content
. Author manuscript; available in PMC: 2020 Jul 15.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2019 Apr 6;104(4):778–789. doi: 10.1016/j.ijrobp.2019.03.051

Fig. 2.

Fig. 2.

Biochemical recurrence-free survival on overall cohort over time. (A) Meta-analysis of biochemical recurrence-free survival at 1, 2, 3, 5, 7, and 10 years post—stereotactic body radiation therapy. Time points are connected for illustrative purposes. (B) Meta-regression assessing the impact of the increasing dose (represented as biologically equivalent dose with an alpha-to-beta ratio of 2.5) on 5-year biochemical recurrence-free survival.